Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
20.45
0.25 (1.24%)
At close: Aug 15, 2025, 10:05 AM

Neurogene Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a -925K n/a 925K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
812K 762K n/a 812K 817K 825K 1.9M 381K 371K 615K 643K 10.82M 718K 661K 631K 592K 542K 512K
Gross Profit
-812K -762K -798K -812K 108K -825K -1.9M -381K -371K -615K -643K -10.82M -718K -661K -631K -592K -542K -512K
Operating Income
-26.08M -25.92M -21.51M -22.18M -20.13M -18.78M -36.51M -5.57M -12.6M -11.72M -14.25M -13M -15.87M -15.37M -15.17M -15.45M -15.12M -14.95M
Interest Income
2.93M 3.21M 2.27M 1.84M 2.04M 2.32M 781K 650K 743K 777K 816K 452K 169K 91.5K 5K 6K 5K 3K
Pretax Income
-22.02M -22.65M -19.51M -20.22M -18.49M -16.92M -15.5M -4.53M -11.86M -14.2M -13.45M -12.55M -15.69M -15.35M -15.17M -15.45M -15.13M -14.95M
Net Income
-22.02M -22.65M -19.51M -20.22M -18.49M -16.92M -15.5M -4.53M -11.86M -14.2M -13.45M -12.55M -15.69M -15.35M -15.17M -15.45M -15.13M -14.95M
Selling & General & Admin
5.9M 8.16M 6.17M 5.89M 5.32M 4.41M 2.55K 4.57M 2.27M 3.41M 3.61M 2.18M 4.2M 4M 4.78M 4.96M 4.76M 4.73M
Research & Development
19.37M 17.76M 15.35M 16.29M 15.74M 13.54M 34.62M 617K 10.32M 7.69M 10M 10.82M 10.96M 10.7M 9.76M 9.9M 9.82M 9.71M
Other Expenses
n/a n/a n/a n/a -817K n/a -2.55K n/a -4K -3K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
25.27M 25.92M 21.51M 22.18M 20.24M 17.95M 34.62M 5.19M 12.6M 11.1M 13.61M 2.18M 15.15M 14.7M 14.54M 14.86M 14.58M 14.44M
Interest Expense
1K 2K 2K 3K 4K 3K 3K 4K 3K 2K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -825K n/a 4.57M n/a 3.41M 3.61M n/a 4.19M 1.56M n/a n/a n/a n/a
Cost & Expenses
26.08M 25.92M 21.51M 22.18M 21.06M 18.78M 36.51M 5.57M 12.6M 11.72M 14.25M 13M 15.87M 15.37M 15.17M 15.45M 15.12M 14.95M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 573.42K n/a n/a n/a n/a -0.00 -0.00 n/a n/a
Shares Outstanding (Basic)
21.06M 21M 14.85M 16.95M 16.94M 16.9M 12.82M 11.1M 56.16M 55.42M 42.65M 5.31M 55.2M 55.14M 42.46M 55.09M 55.03M 54.94M
Shares Outstanding (Diluted)
21.06M 21M 14.85M 16.95M 16.94M 16.9M 12.82M 11.1M 56.16M 55.42M 42.65M 5.31M 55.2M 55.14M 42.46M 55.09M 55.03M 54.94M
EPS (Basic)
-1.05 -1.08 -1.31 -1.19 -1.09 -1 -1.21 -0.41 -0.21 -0.26 -0.32 -2.36 -0.28 -0.28 -0.36 -0.28 -0.27 -0.27
EPS (Diluted)
-1.05 -1.08 -1.31 -1.19 -1.09 -1 -1.21 -0.41 -0.21 -0.26 -0.32 -2.36 -0.28 -0.28 -0.36 -0.28 -0.27 -0.27
EBITDA
-21.2M -21.88M -18.71M -19.4M -17.67M -16.09M -18.28M -4.14M -11.77M -12.22M -12.8M -12.21M -14.97M -14.69M -14.54M -14.85M -14.59M -14.44M
EBIT
-22.02M -22.64M -19.51M -20.21M -18.49M -16.92M -20.17M -4.53M -12.6M -12.26M -13.45M -13M -15.69M -15.35M -15.17M -15.45M -15.13M -14.95M
Depreciation & Amortization
812K 762K 798K 807K 817K 825K 1.9M 381K 371K 615K 643K 792K 718K 661K 631K 592K 542K 512K